Infection and Immunity, November 2000, p. 6370-6377, Vol. 68, No. 11
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Department of Cell and Molecular Biology, Section for Molecular Pathogenesis, Lund University, Lund, Sweden
Received 26 June 2000/Returned for modification 11 August 2000/Accepted 21 August 2000
| |
ABSTRACT |
|---|
|
|
|---|
Surface proteins of Streptococcus pyogenes are important virulence factors. Here we describe a novel collagen-like surface protein, designated SclA (streptococcal collagen-like surface protein). The sclA gene was identified in silico using the Streptococcal Genome Sequencing Project with the recently identified protein GRAB as the probe. SclA has a signal sequence and a cell wall attachment region containing the prototypic LPXTGX motif. The surface-exposed part of SclA contains a unique NH2-terminal domain of 73 amino acids, followed by a collagen-like region. The sclA gene was found to be positively regulated by Mga, a transcriptional activator of several S. pyogenes virulence determinants. A mutant lacking cell wall-associated SclA was constructed and was found to be as effective as wild-type bacteria in platelet aggregation, survival in fresh human blood, and adherence to pharyngeal cells. The sclA gene was found in all 12 S. pyogenes strains that were investigated using PCR. Sequence analysis revealed that the signal sequence and the cell wall attachment region are highly conserved. The collagen-like domain is variable in its NH2-terminal region and has conserved repeated domains in its COOH-terminal part. SclA proteins from most strains have additional proline-rich repeats spacing the collagen-like domain and the cell wall attachment sequence. The unique NH2-terminal region is hypervariable, but computer predictions indicate a common secondary structure, with two alpha helices connected by a loop region. Immune selection may explain the hypervariability in the NH2-terminal region, whereas the preserved secondary structure implies that this region has a common function. These features and the Mga regulation are shared with the M protein of S. pyogenes. Moreover, as with the gene encoding the M protein, phylogenetic analysis indicates that horizontal gene transfer has contributed to the evolution of sclA.
| |
INTRODUCTION |
|---|
|
|
|---|
Streptococcus pyogenes is
an important pathogen causing the common diseases pharyngitis,
erysipelas, and impetigo. Sometimes this organism causes severe
invasive diseases, such as a toxic shock-like syndrome and necrotizing
fasciitis. Nonsuppurative sequelae following infection with S. pyogenes include acute rheumatic fever and poststreptococcal
glomerulonephritis. The cell wall-anchored proteins of S. pyogenes are regarded as major virulence determinants and share
common features, including a signal sequence and a cell wall attachment
signal containing a so-called LPXTGX motif (39). Among the
best-characterized and most important cell wall-attached proteins are
the alpha-helical coiled-coil M and M-like proteins (see references
15 and 51). Each S. pyogenes strain carries one to three genes encoding M or M-like
proteins, and these genes are colocated on the chromosome with the
mga gene encoding their positive regulator, Mga (7, 22,
36, 42, 45). The scpA gene encoding the cell
wall-attached C5a-peptidase is also located at this chromosomal site
(44, 60). The M and M-like proteins bind several plasma
proteins, such as fibrinogen (30), IgA (37), IgG
(1, 20), serum albumin (16, 50, 56), plasminogen (4), kininogens (3), and regulatory proteins of
the complement system (23, 59). The binding sites for these
ligands are found both in the conserved COOH- and in the variable
NH2-terminal regions of the protein (39). The
binding activities are probably important for the antiphagocytic
properties of M proteins. Other cell wall-anchored proteins in S. pyogenes containing the LPXTGX motif include the fibronectin
binding protein F (Sfb1) and PFBP (18, 52, 58), the
fibronectin binding apolipoproteinase serum opacity factor (47,
55), and the
2-macroglobulin binding protein GRAB
(48). In this work we describe a novel and widespread gene,
regulated by Mga, encoding a cell wall-anchored protein of S. pyogenes. SclA (streptococcal collagen-like surface protein) has a
typical cell wall anchor and signal sequence, whereas the
surface-exposed part of the molecule comprises a region with homology
to collagen and a hypervariable NH2-terminal part.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains and growth conditions.
S. pyogenes
strains designated AP are from the Institute of Hygiene and
Epidemiology, Prague, Czech Republic. The KTL3 and KTL9 strains are
blood isolates from the Finnish Institute for Health. The SF370 strain
is the ATCC 700294 strain. BMJ71 is an isogenic AP1 mutant containing a
Tn916 insertion within mga (33). BMJ71pMGA.1 is a derivate of BMJ71 containing mga on a
plasmid (33). For molecular cloning purposes, the BL21 or
the DH5
strain of Escherichia coli was used. Streptococci
were grown in Todd-Hewitt broth (Difco, Detroit, Mich.) with 0.2%
yeast extract (THY) (Difco) in 5% CO2 at 37°C. For
growth of mga mutants, appropriate antibiotics were added
(33). E. coli strains were grown in Luria Bertani broth (10 g of tryptone [Difco]/liter, 10 g of NaCl/liter,
5 g of yeast extract [Difco]/liter). For growth on Petri dishes,
15 g of bacto agar (Difco)/liter was added. When E. coli contained a plasmid, either 100 µg of ampicillin (Sigma,
St. Louis, Mo.)/ml or 50 µg of kanamycin (Sigma)/ml was added to the medium.
PCR, cloning procedures, and sequencing.
Genomic DNA was
prepared from S. pyogenes as described previously
(43) with modifications as described previously
(48). PCR was performed using Taq polymerase
(Gibco-BRL, Gaithersburg, Md.) and synthetic oligonucleotides
hybridizing to sclA. Primers hybridized to the following
nucleotides found in the Streptococcal Genome Sequencing database (the
introduced restriction site and the position of the site are given in
parentheses): F1, nucleotide (nt) 199208-199236; F2, nt 199372-199400 (BamHI at position 199377-199383); F3, nt 199430-199455 (BamHI at position 199436-199442); R1, nt 200120-200100 (HindIII at position 200114-200109); and R2,
200206-200183 (XhoI at position 200201-200196). Restriction
enzymes and ligase were from Gibco-BRL, and standard ligation,
transformation, and plasmid isolation methods were used
(54). PCR products were generated using primers F1 and R2,
and DNA sequences were determined using an ABI-470 prism and
Taq-dyed dideoxy terminator kit (Perkin and Elmer, Norwalk,
Conn.). For expression cloning, primers F2 and R2 were used in PCR with
AP1 DNA, and the restriction enzyme-cleaved product was ligated into
the corresponding site of pGEX-5X-3 (Pharmacia Biotech, Uppsala,
Sweden). The resulting plasmid was transformed into BL21 bacteria,
which upon induction with 0.5 mM isopropyl-
-thiogalactopyranoside (Promega) produced a fusion protein between glutathione
S-transferase (GST) and SclA. The fusion protein was
purified by affinity chromatography according to the instructions of
the manufacturer. Sequencing of the plasmid insert confirmed that the
correct sequence had been cloned. To generate a mutant devoid of SclA
on its surface, a fragment of sclA, lacking the part
encoding the putative cell wall attachment region, was generated by PCR
from the AP1 strain using primers F3 and R1. The fragment was treated
with appropriate restriction enzyme, ligated into the streptococcal
suicide plasmid pFW13 (46), a kind gift from Andreas
Podbielski, to generate pFW-sclA, and transformed into
DH5
. The plasmid was purified, and 2 µg of the plasmid was
electroporated into the AP1 strain (19) for homologous
recombination to occur. Transformants were plated on THY plus 15 g
of agar/liter with 150 µg of kanamycin/ml.
Blotting techniques.
Twenty micrograms of chromosomal DNA,
purified as described above, was cleaved by HindIII,
separated by agarose gel electrophoresis, and blotted onto Hybond-N
filters (Amersham, Amersham, United Kingdom) using standard protocols
(54). Total RNA from S. pyogenes was purified
using a Fastprep cell disrupter (Savant, Holbrok, N.Y.) as previously
described (9). Streptococci were cultured in THY medium to
an optical density at 620 nm (OD620) of 0.3 (early logarithmic phase), an OD620 of 0.6 (late logarithmic
phase), or an OD620 of 0.8 (early stationary phase) before
harvest by centrifugation at 3,800 × g for 10 min at
4°C. Pellets were resuspended in water, followed by disruption for
20 s (2 times) at setting 6.0 using a FastRNA kit with glass beads
(BIO 101, Vista, Calif.) according to the instructions from the
manufacturers. For Northern blot experiments, 5 µg of total RNA was
separated on 1% agarose in 1× HEPES buffer (0.2 M Na-HEPES [pH
7.0], 50 mM NaAc, 10 mM EDTA) containing 2.3 M formaldehyde and
blotted onto Hybond-N. RNA or DNA was cross-linked to the filter using
a Spectrolinker XL-1000 UV Crosslinker, prehybridized for 2 h, and
hybridized overnight at 50°C with a probe generated by PCR from AP1
using primers F2 and R2 and labeled as described (48). This
probe hybridizes with the part of sclA encoding the A, CLR,
and W regions (see Fig. 1). Filters were also hybridized with a probe
constructed from a 16S ribosomal RNA sequence of S. pyogenes
(48). After hybridization, the membranes were washed in 6
0.1× SSC-0.1% sodium dodecyl sulfate (SDS) (1× SSC is 0.15 M NaCl
plus 0.115 M sodium citrate), followed by exposure of a BAS-III imaging
plate and scanning with a Bio-Imaging Analyzer BAS-2000 (Fuji Photo
Films Co. Ltd.). Intensities of bands were calculated using the Image Gauche program.
Antiserum, protein separation, and Western blotting. Rabbit antiserum against SclA was generated by injecting 50 µg of purified GST-SclA protein with an equal volume of Freunds adjuvant (1/3 complete and 2/3 incomplete) subcutaneously into rabbits. This was repeated after 4 weeks, blood was drawn 6 weeks after the first immunization, and serum was prepared. Proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) (40) and transferred to a Protane nitrocellulose filter (Schleicher & Shuell, Dassel, Germany) using a Trans-blot semidry transfer cell (Bio-Rad, Hercules, Calif.). Filters were blocked using phosphate-buffered saline with 0.05% Tween 20 and 5% dry milk powder (blocking buffer), followed by incubation of the filter with antiserum (1:5,000) in 5 ml of the same buffer for 30 min at 37°C. Membranes were washed 3 times for 10 min using phosphate-buffered saline with 0.05% Tween 20 and 0.5 M NaCl, followed by incubation of the filter with a peroxidase-conjugated antibody against rabbit immunoglobulin (1:3,000) in blocking buffer. Filters were washed as described above, and detection of bound antibodies was performed with the chemiluminescence method.
Other methods. The tBLASTn service (www.genome.ou.edu/strep.html) was used to search the database of the Streptococcal Genome Sequencing Project. Other homology searches were made using the BLAST 2.0 program (www.ncbi.nlm.nih.gov). Signal sequence predictions were made using the SignalP V1.1 program (www.cbs.dtu.dk) (41). Phylogenetic analyses of the NH2-terminal region of the M protein and the A domain of SclA were performed (http: //bioweb.pasteur.fr) using parsimony analysis. Secondary structure and pI predictions were performed using MacVector (Oxford Molecular Ltd., version 6.5). Platelet aggregonometry was performed as described previously (35). Adherence of streptococci to the human pharynx carcinoma cell line Detroit 562 (ATCC CCL-138) was tested as described previously (5). Proteins were precipitated by incubation with 6% trichloroacetic acid (TCA) for 30 min on ice, followed by centrifugation at 15,000 × g (4°C for 20 min).
Nucleotide sequence accession numbers. The sclA and SclA sequences have been deposited in GenBank under accession no. AF296329 to AF296339.
| |
RESULTS |
|---|
|
|
|---|
Identification of a novel collagen-like surface protein (SclA) in S. pyogenes. Cell wall-anchored proteins of gram-positive bacteria share common structural features, including an LPXTGX motif, a cell membrane-spanning hydrophobic region, and a short charged intracellular tail (for a review see reference 39). To identify open reading frames encoding putative cell wall-anchored proteins, a tBLASTn search against the Streptococcal Genome Sequencing Project was performed using the W and M regions of the recently discovered protein GRAB (48) as the query sequence. Besides grab, this search revealed three open reading frames encoding proteins with an LPXTGX motif, followed by a hydrophobic sequence and a short charged sequence. One of the predicted proteins lacked a putative signal sequence, while the second was similar to an alkaline amylopullolanase from Bacillus spp. The third open reading frame (positions 199241 to 200284 in the Streptococcal Genome Sequencing Project database) encodes a protein with similarities to collagen, and the present work is focused on this streptococcal collagen-like surface protein (SclA).
A schematic representation of the SclA protein is shown in Fig. 1. In the NH2-terminal region is a putative 37-amino-acid (aa)-long signal sequence as predicted from the signalP program. This region is followed by a 73-aa A domain with no significant similarity to any other protein. The collagen-like region (CLR) consists of 171 amino acid residues with a glycine in every third position and is rich in proline residues (10%). In the COOH-terminal part of the CLR are two partially overlapping repeated motifs. The type 1 repeats are 15 aa in length and are composed entirely of collagen-like GXY units, while the type 2 repeat is 16 aa and consists predominantly of GXY units. Each pair of repeats contains a single mismatch. The CLR is similar to several types of collagen from different species, including human collagens. The CLR is followed by a putative cell wall-spanning domain (W) which includes the LPATGE sequence. The membrane-spanning domain (M) consists of 19 hydrophobic residues followed by 6 charged residues in the extreme COOH-terminal region. The W and M regions are similar to the corresponding domains of several M proteins. The mature SclA protein has a calculated molecular mass of 29 kDa and an estimated pI of 5.26.
|
The sclA gene is transcriptionally controlled by
Mga.
The expression of sclA was investigated using
Northern blotting, in which total RNA from the AP1 strain was prepared
at different stages of growth. Maximal expression of sclA
was seen in early logarithmic growth phase, with lower amounts of
transcript in late logarithmic growth phase (Fig.
2A). In early stationary phase, almost no
sclA transcript was detected. The same filter was hybridized with a 16S probe, showing that the same amount of RNA had been applied
to each well (data not shown). Several surface proteins implicated in
the virulence of S. pyogenes are transcriptionally activated
by a protein termed Mga (7, 42, 45). An isogenic mutant of
AP1, with a transposon insertion within mga, was therefore tested for sclA expression, and it was found that this
mutant (BMJ71) was devoid of the sclA transcript in three
independent experiments (Fig. 2B). The expression of sclA
was almost completely restored in the BMJ71pMGA.1 strain (77 and 92%
of the AP1 level in two separate experiments), which harbors
mga on a plasmid (Fig. 2B). Again, the filter shown in Fig.
2B was hybridized with a 16S probe, confirming that the same amount of
RNA had been applied to each well (data not shown). The Mga protein
exerts its effects by binding to a so-called Mga-binding element, and
the consensus sequence for this element (38) was compared to
the DNA sequence upstream from sclA. Indeed, a DNA sequence
was identified for which 34 out of 40 nt were identical to the
consensus sequence. This sequence was found 108 to 147 bp upstream from
the start codon of sclA (Fig. 2C). Moreover, putative
35
and
10 boxes, similar to those described for the emm and
scpA genes (38), were located within and
downstream from this element, respectively (Fig. 2C).
|
Generation and characterization of a mutant lacking
surface-associated SclA.
The entire mature SclA (aa 37 to 322 in
Fig. 1) was expressed as a fusion protein with GST. The protein could
be purified in small quantities and had a tendency to precipitate. The
GST-SclA protein migrated with an apparent size of approximately 65 kDa, which is somewhat larger than expected (Fig.
3). However, it is common for the sizes
of cell wall proteins from gram-positive bacteria to be overestimated
by SDS-PAGE (31, 48). The fusion protein was used to
immunize rabbits, and the polyclonal antiserum reacted specifically
with the GST-SclA protein fusion (Fig. 3, right panel).
|
,
was selected for further analysis. Southern blot analysis confirmed that a single crossover event had taken place at the sclA
locus (data not shown). With this mutagenesis strategy the mutant
should be devoid of surface bound SclA and instead secrete a truncated form (aa 38 to 294 in Fig. 1). Accordingly, when the supernatants from
overnight cultures of AP1 and SclA
were precipitated with
TCA and subjected to Western blotting using the SclA antiserum, the
SclA
strain was found to secrete a protein with an
apparent mass of approximately 32 kDa which was not identified in the
AP1 medium (Fig. 4B). The other proteins recognized by this antiserum
were also recognized by the preimmune serum (Fig. 4B). The predicted size of the SclA protein secreted by SclA
is 27 kDa, but
as with the GST-SclA fusion it migrated more slowly in SDS-PAGE.
SclA
and AP1 bacteria had similar growth characteristics
in THY medium and showed identical binding of fibrinogen and
immunoglobulin G (data not shown). Binding of glycoproteins, such as
thyroglobulin, to S. pyogenes is mediated by an
Mga-regulated protein distinct from the M protein (26).
Binding of radiolabeled thyroglobulin to the SclA
mutant
was found to be identical to that of MC25 (an M-negative mutant of AP1,
generated using pFW13) (11), while the level of binding to
BMJ71 was much lower (data not shown). SclA
as well as
AP1 survived in fresh human blood and showed identical adherence to a
pharyngeal cell line (data not shown). Since several reports have shown
that a collagen-like surface protein of Streptococcus sanguis induces aggregation of human platelets (12,
13), the SclA
strain was compared with AP1 in a
platelet aggregonometric assay. As was previously reported for other
S. pyogenes strains (35), AP1 bacteria were able
to induce a complete aggregation of platelets in platelet-rich plasma
within less than 1 min. SclA
bacteria were equally
effective in inducing aggregation. Moreover, the GST-SclA protein added
in concentrations of up to 0.1 mg/ml to platelet-rich plasma was able
neither to induce aggregation of platelets nor to influence the
aggregation of platelets mediated by AP1 or SclA
bacteria
(data not shown).
|
Distribution, sequencing, and genetic analysis of the SclA protein. The presence of sclA in S. pyogenes strains was investigated by Southern blotting, and all strains (12 of 12) had a single chromosomal fragment reacting with the sclA probe (data not shown). Primers F1 and R2 (see Materials and Methods) were used in PCR to amplify a large fragment of sclA. Depending on the template DNA used, a fragment of 0.9 to 1.5 kb was obtained. These fragments were subjected to sequencing.
A schematic comparison between the predicted mature SclA protein from the database sequence and the predicted mature SclA proteins from the strains sequenced in this work is shown in Fig. 5A. The SclA proteins from the three M1 strains are identical, while the SclA proteins from different serotypes are divergent. The signal sequences are >95% conserved among the 12 strains (not shown). The A domains, however, differ in sequence, and the identity between the A domains varies between 22 and 70% in a pairwise ClustalW alignment. The A domain of AP15 shows the lowest degree of identity to the other A domains, while the A domains of AP12 and AP49 show the highest degree of identity. The A domains have some features in common, the first of which is a prediction for two alpha helices using two different computer algorithms (10, 17). Figure 5B summarizes the alpha helix predictions for the A domains of SclA from the 10 different serotypes. A region was regarded as helical only when both algorithms predicted it to be so. The predictions indicate that the majority of A domains have one alpha helix from aa 48 to aa 62 and a second alpha helix between aa 86 and 104. The loop region between the two helices is 19 ± 4.5 aa (mean ± the standard deviation), excluding the A domains of M1 and AP15. The A domain of the SclA protein from M1 bacteria is predicted to have a short helix within the loop region, while the A domain of SclA from AP15 has three predicted helices. The second striking feature of the A domain is the high content of aromatic amino acids in the loop region spacing the two helices: 28% ± 7% as compared to 11% ± 3% for the entire A domain (mean ± the standard deviation). None of the A domains showed any significant similarity to sequences deposited in databases.
|
antigen (27) from
Streptococcus agalactiae. The SclA protein of AP9 has three
divergent proline-rich repeats containing two or five additional amino
acid residues and one copy of the consensus repeat. The W domain is
>95% conserved among all the proteins and contains the LPATGE motif.
The calculated molecular mass of the mature SclA protein varies from 25 kDa for AP15 to 40 kDa for AP12. Despite the variation in size and
sequence, the proteins all have a predicted acidic pI ranging from 4.7 to 5.2.
The level of similarity between the A domains of different SclA
proteins is too low to allow a stringent phylogenetic analysis. However, a few possible phylogenetic dendrograms were obtained and
compared with similar dendrograms obtained for the hypervariable NH2-terminal part of different M proteins (61).
No correlation was found between any of the dendrograms generated for
the SclA and the M proteins (data not shown).
| |
DISCUSSION |
|---|
|
|
|---|
In this work we describe a novel surface protein of S. pyogenes containing a collagen-like region. Collagen is a triple-helical, elongated protein structure which is the dominating structural component of the extracellular matrix of all multicellular organisms. Moreover, collagens interact specifically with several macromolecules (see reference 53). Collagen-like sequences are found in other proteins, such as C1q of the complement system (49) and the scavenger receptor on macrophages (34), where these sequences are believed to play both structural and functional roles (53, 57). The CLR of SclA could by analogy serve both as a ligand-binding site and as a stalk on which the hypervariable NH2-terminal A domain is exposed. Collagen-like sequences are not limited to proteins of multicellular organisms but can also be found in bacterial proteins. For example, a collagen-like sequence stabilizes homotrimers of a pullulanase in Klebsiella pneumoniae (8). In S. pyogenes, two extracellular hyaluronidases have been reported to contain short stretches of collagen-like sequences (24, 25). Moreover, a collagen-like surface antigen of S. sanguis has been shown to induce aggregation of platelets (12, 13). A collagen-like heptapeptide was found to be responsible for this effect (14), but the sequence of the intact protein is unknown. The CLR of SclA is, however, the longest collagen-like sequence of a bacterial protein so far described. Moreover, SclA is not involved in platelet aggregation and is thus distinct from the collagen-like immunodeterminant at the surface of S. sanguis.
The SclA protein has several characteristics of a surface protein of gram-positive bacteria, including a signal sequence and a cell wall anchor containing the LPXTGX motif. SclA contains proline-rich repeats in the COOH-terminal part of the protein, which is also common for surface proteins in gram-positive bacteria. The number of proline-rich repeats varies between different streptococcal strains, much like the repeats in the protein GRAB (48). The type 1 to type 4 repeats are all collagen-like and are located in the conserved COOH-terminal part of the CLR. These repeats are less well defined and are sometimes overlapping.
The SclA protein has several features in common with streptococcal M proteins. M proteins are rod-like alpha-helical coiled-coil proteins which protrude from the streptococcal cell surface. In SclA it is likely that the CLR forms such an elongated and rod-like structure, which could serve to present the hypervariable A domain at the bacterial surface. Furthermore, both the M protein and SclA have conserved COOH-terminal parts, while both proteins exhibit hypervariable NH2-terminal domains. The hypervariable regions of SclA proteins, however, share a common secondary structure as judged from computerized predictions. All A domains have a strong prediction to form two alpha helices connected by a loop region rich in aromatic amino acids. Despite the lack of sequence conservation, the hypervariable NH2-terminal regions of several M proteins have recently been shown to bind C4BP, a regulatory protein of the complement system (29). Only one M protein tested failed to bind C4BP, and this M protein had a secondary structure prediction in the hypervariable region different from that for the others (29). Also, the hypervariable NH2-terminal regions of M5 and M6 have an affinity for FHL1, another regulatory protein of the complement system (28). It therefore appears plausible that the hypervariable NH2-terminal regions of SclA showing a conserved secondary structure interact with a common ligand and have common function(s). However, among a large number of tested human proteins, we have failed to identify any that interacts with SclA.
Within a given serotype, the M protein is conserved. Antibodies to the hypervariable part of M proteins are opsonizing, and therefore the differences between M proteins of different serotypes can be explained as a means by which S. pyogenes avoids cross-serotype immunity. It seems likely that the hypervariability of SclA is also due to a selective pressure to avoid cross-serotype-reacting antibodies. Interestingly, there seems to be a correlation between the M serotype and the sequence of SclA. Thus, SclA sequences of the three M1 strains studied here are completely conserved, as is the case for 95% of M1 proteins (21). Therefore, a given M serotype seems to have a distinct SclA type.
Genes encoding M proteins are subjected to horizontal gene transfer (32), and it is possible that at least one case of horizontal gene transfer of the sclA gene has occurred among the S. pyogenes strains studied in this work. There is no special structural similarity between the M12 and M49 proteins and no overall chromosomal relationship of the M12 and M49 strains (61). Nevertheless, the SclA proteins of these two strains are very similar compared to any other pair of SclA proteins. Another striking similarity between the M proteins and SclA is related to their gene regulation. Both genes are under the transcriptional control of the Mga protein. The coregulation of these two surface proteins will result in their simultaneous exposure at the bacterial surface, suggesting that they play a role during the same phase of an infection. It is noteworthy that Mga regulates the expression of additional genes implicated in the virulence of S. pyogenes, including the scpA gene, encoding the C5a peptidase (36, 45, 60) and the sic gene, encoding the complement regulator protein SIC (2, 33). This suggests also that SclA could contribute to the virulence of S. pyogenes, a possibility which will be investigated in future studies.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grants from the Swedish Medical Research Council (project 7480); the Medical Faculty, Lund University; the Foundations of Kock, Lundberg, and Österlund; the Göran Gustavsson Foundation for Research in Natural Sciences and Medicine; and Active Biotech Ltd.
We acknowledge the Streptococcal Genome Sequencing Project, funded by USPHS/NIH grant AI38406, and B. A. Roe, S. P. Linn, L. Song, X. Yuan, S. Clifton, M. McShan, and J. Ferretti. We thank Andreas Podbielski for providing the pFW13 plasmid and Axel Janke for important advice.
| |
ADDENDUM |
|---|
The gene described herein was originally designated coss, but after the submission of the manuscript, the same sequence from strain SF370 (sequenced in the Streptococcal Genome Sequence Project) was made public in GenBank under accession no. AF252861. The submission was done by S. Lukomski et al. based on unpublished results, and the gene was designated scl. We thus chose to denote the gene described herein sclA since after submission of the manuscript we found that several S. pyogenes strains express an additional Scl-like protein.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Cell and Molecular Biology, Section for Molecular Pathogenesis, Lund University, P.O. Box 94, S 221 00 Lund, Sweden. Phone: 46-46-2224489. Fax: 46-46-157756. E-mail: magnus.rasmussen{at}medkem.lu.se.
Editor: E. I. Tuomanen
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Åkesson, P.,
J. Cooney,
F. Kishimoto, and L. Björck.
1990.
Protein H a novel IgG binding bacterial protein.
Mol. Immunol.
6:523-531.
|
| 2. |
Åkesson, P.,
A. G. Sjöholm, and L. Björck.
1996.
Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function.
J. Biol. Chem.
271:1081-1088 |
| 3. | Ben Nasr, A., H. Herwald, W. Müller-Esterl, and L. Björck. 1995. Human kininogens interact with M protein, a bacterial surface protein and virulence determinant. Biochem. J. 305:173-180. |
| 4. |
Berge, A., and U. Sjöbring.
1993.
PAM, a novel plasminogen-binding protein from Streptococcus pyogenes.
J. Biol. Chem.
268:25417-25424 |
| 5. | Berry, A. M., and J. C. Paton. 1996. Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae. Infect. Immun. 64:5255-5262[Abstract]. |
| 6. |
Brooks-Walter, A.,
D. E. Briles, and S. K. Hollingshead.
1999.
The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia.
Infect. Immun.
67:6533-6542 |
| 7. |
Caparon, M. G., and J. R. Scott.
1987.
Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci.
Proc. Natl. Acad. Sci. USA
84:8677-8681 |
| 8. | Charalambous, B. M., J. N. Keen, and M. J. McPherson. 1988. Collagen-like sequences stabilize homotrimers of a bacterial hydrolase. EMBO J. 7:2903-2909[Medline]. |
| 9. | Cheung, A. L., K. I. Eberhardt, and V. A. Fischetti. 1994. A method to isolate RNA from Gram-positive bacteria and mycobacteria. Anal. Biochem. 222:511-514[CrossRef][Medline]. |
| 10. | Chou, P. Y., and G. D. Fasman. 1974. Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. Relat. Areas Mol. Biol. 47:45-148. |
| 11. | Collin, M., and A. Olsén. 2000. Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein. Mol. Microbiol. 36:1306-1318[CrossRef][Medline]. |
| 12. | Erickson, P. R., and M. C. Herzberg. 1987. A collagen-like immunodeterminant on the surface of Streptococcus sanguis induces platelet aggregation. J. Immunol. 138:3360-3366[Abstract]. |
| 13. |
Erickson, P. R., and M. C. Herzberg.
1990.
Purification and partial characterization of a 65-kDa platelet aggregation-associated protein antigen from the surface of Streptococcus sanguis.
J. Biol. Chem.
265:14080-14087 |
| 14. |
Erickson, P. R., and M. C. Herzberg.
1993.
The Streptococcus sanguis platelet aggregation-associated protein, identification and characterization of the minimal platelet-interacting domain.
J. Biol. Chem.
268:1646-1649 |
| 15. |
Fischetti, V. A.
1989.
Streptococcal M protein: molecular design and biological behavior.
Clin. Microbiol. Rev.
2:285-314 |
| 16. |
Frick, I.-M.,
P. Åkesson,
J. Cooney,
U. Sjöbring,
K.-H. Schmidt,
H. Gomi,
S. Hattori,
C. Tagawa,
F. Kishimoto, and L. Björck.
1994.
Protein H a surface protein of Streptococcus pyogenes with separate binding sites for IgG and albumin.
Mol. Microbiol.
12:143-151[Medline].
|
| 17. | Garnier, J., D. J. Osguthorpe, and B. Robson. 1978. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J. Mol. Biol. 120:97-120[CrossRef][Medline]. |
| 18. |
Hanski, E., and M. Caparon.
1992.
Protein F, a fibronectin-binding protein, is an adhesin of the group A streptococcus Streptococcus pyogenes.
Proc. Natl. Acad. Sci. USA
89:6172-6176 |
| 19. | Hanski, E., G. Fogg, A. Tovi, N. Okada, I. Burstein, and M. Caparon. 1995. Molecular analysis of Streptococcus pyogenes adherence. Methods Enzymol. 253:269-305[Medline]. |
| 20. |
Heath, D. G., and P. P. Cleary.
1987.
Cloning and expression of the gene for an immunoglobulin G Fc receptor protein from a group A streptococcus.
Infect. Immun.
55:1233-1238 |
| 21. | Hoe, N. P., K. Nakashima, S. Lukomski, D. Grigsby, M. Liu, P. Kordari, S. J. Dou, X. Pan, J. Vuopio-Varkila, S. Salmelinna, A. McGeer, D. E. Low, B. Schwartz, A. Schuchat, S. Naidich, D. De-Lorenzo, Y. X. Fu, and J. M. Musser. 1999. Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves. Nat. Med. 5:924-929[CrossRef][Medline]. |
| 22. | Hollingshead, S. K., T. L. Readdy, D. L. Yung, and D. E. Bessen. 1993. Structural heterogeneity of the emm gene cluster in group A streptococci. Mol. Microbiol. 8:707-717[Medline]. |
| 23. |
Horstmann, R. D.,
H. J. Sievertsen,
J. Knobloch, and V. A. Fischetti.
1988.
Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.
Proc. Natl. Acad. Sci. USA
85:1657-1661 |
| 24. |
Hynes, W. L., and J. J. Ferretti.
1989.
Sequence analysis and expression in Escherichia coli of the hyaluronidase gene of Streptococcus pyogenes bacteriophage H4489A.
Infect. Immun.
57:533-539 |
| 25. | Hynes, W. L., L. Hancock, and J. J. Feretti. 1995. Analysis of a second bacteriophage hyaluronidase gene from Streptococcus pyogenes: evidence for a third hyaluronidase involved in extracellular enzymatic activity. Infect. Immun. 63:3015-3020[Abstract]. |
| 26. |
Hytonen, J.,
S. Haataja,
P. Isomäki, and J. Finne.
2000.
Identification of a novel glycoprotein-binding activity in Streptococcus pyogenes regulated by the mga gene.
Microbiology
146:31-39 |
| 27. | Jerlestrom, P. G., G. S. Chhatwal, and K. N. Timmis. 1991. The IgA-binding beta antigen of the c protein complex of group B streptococci: sequence determination of its gene and detection of two binding regions. Mol. Microbiol. 5:843-849[CrossRef][Medline]. |
| 28. |
Johnsson, E.,
K. Berggård,
H. Kotarsky,
J. Hellwage,
P. F. Zipfel,
U. Sjöbring, and G. Lindahl.
1998.
Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor.
J. Immunol.
161:4894-4901 |
| 29. | Johnsson, E., A. Thern, B. Dahlbäck, L.-O. Hedén, M. Wikström, and G. Lindahl. 1996. A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP. J. Immunol. 157:3021-3029[Abstract]. |
| 30. | Kantor, F. S. 1965. Fibrinogen precipitation by streptococcal M protein. J. Exp. Med. 121:849-859[Abstract]. |
| 31. |
Kastern, W.,
U. Sjöbring, and L. Björck.
1992.
Structure of peptostreptococcal protein L and identification of a repeated immunoglobulin light chain-binding domain.
J. Biol. Chem.
267:12820-12825 |
| 32. | Kehoe, M. A., V. Kapur, A. M. Whatmore, and J. M. Musser. 1996. Horizontal gene transfer among group A streptococci: implications for pathogenesis and epidemiology. Trends Microbiol. 4:436-443[CrossRef][Medline]. |
| 33. | Kihlberg, B.-M., J. Cooney, M. G. Caparon, A. Olsén, and L. Björck. 1995. Biological properties of a Streptococcus pyogenes mutant generated by Tn916 insertion in mga. Microb. Pathog. 19:299-315[Medline]. |
| 34. | Kodama, T., M. Freeman, L. Rohrer, J. Zabrecky, P. Matsudaira, and M. Krieger. 1990. Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 343:531-535[CrossRef][Medline]. |
| 35. |
Kurpiewski, G. E.,
L. J. Forrester,
B. J. Campbell, and J. T. Barret.
1983.
Platelet aggregation of Streptococcus pyogenes.
Infect. Immun.
39:704-708 |
| 36. | La Penta, D., X. P. Zhang, and P. P. Cleary. 1994. Streptococcus pyogenes type IIa IgG Fc receptor expression is co-ordinately regulated with M protein and streptococcal C5a peptidase. Mol. Microbiol. 12:873-879[CrossRef][Medline]. |
| 37. | Lindahl, G., and B. Åkerström. 1989. Receptor for IgA in group A streptococci: cloning of the gene and characterization of the protein expressed in Escherichia coli. Mol. Microbiol. 3:239-247[CrossRef][Medline]. |
| 38. |
McIver, K. S.,
A. S. Heath,
B. D. Green, and J. R. Scott.
1995.
Specific binding of the Mga to promoter sequences of the emm and scpA genes in the group A streptococcus.
J. Bacteriol.
177:6619-6624 |
| 39. |
Navarre, W. W., and O. Schneewind.
1999.
Surface proteins of Gram-positive bacteria and mechanisms of their targeting to the cell wall envelope.
Microbiol. Mol. Biol. Rev.
63:174-229 |
| 40. |
Neville, D. M.
1971.
Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system.
J. Biol. Chem.
246:6328-6334 |
| 41. |
Nielsen, H.,
J. Engelbrecht,
S. Brunak, and G. von Heijne.
1997.
Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites.
Protein Eng.
10:1-6 |
| 42. |
Perez-Casal, J.,
M. G. Caparon, and J. R. Scott.
1991.
Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems.
J. Bacteriol.
173:2617-2624 |
| 43. | Pitcher, D. G., N. A. Saunders, and R. J. Owen. 1989. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett. Appl. Microbiol. 8:151-156. |
| 44. | Podbielski, A. 1993. Three different types of organization of the vir regulon in group A streptococci. Mol. Gen. Genet. 237:287-300[Medline]. |
| 45. | Podbielski, A., A. Flosdorff, and J. Weber-Heynemann. 1995. The group A streptococcal virR49 gene controls expression of four structural vir regulon genes. Infect. Immun. 63:9-20[Abstract]. |
| 46. | Podbielski, A., B. Spellerberg, M. Woischnik, B. Pohl, and R. Lüttiken. 1996. Novel series of plasmid vectors for gene inactivation and expression analysis in group A streptococci (GAS). Gene 177:137-147[CrossRef][Medline]. |
| 47. | Rakonjac, J. V., J. C. Robbins, and V. A. Fischetti. 1995. DNA sequence of the serum opacity factor of group A streptococci: identification of a fibronectin-binding domain. Infect. Immun. 63:622-631[Abstract]. |
| 48. |
Rasmussen, M.,
H.-P. Müller, and L. Björck.
1999.
Protein GRAB of Streptococcus pyogenes regulates proteolysis at the bacterial cell surface by binding 2-macroglobulin.
J. Biol. Chem.
274:15336-15344 |
| 49. | Reid, K. B. 1979. Complete amino acid sequences of the three collagen-like regions present in subcomponent C1q of the first component of human complement. Biochem. J. 179:367-371[Medline]. |
| 50. |
Retnoningrum, D. S., and P. P. Cleary.
1994.
M12 protein from Streptococcus pyogenes is a receptor for immunoglobulin G3 and human albumin.
Infect. Immun.
62:2387-2394 |
| 51. | Robinson, J. H., and M. A. Kehoe. 1992. Group A streptococcal M proteins: virulence factors and protective antigens. Immunol. Today 13:362-367[CrossRef][Medline]. |
| 52. |
Rocha, C. L., and V. A. Fischetti.
1999.
Identification and characterization of a novel fibronectin-binding protein on the surface of group A streptococci.
Infect. Immun.
67:2720-2728 |
| 53. | Rohrer, L., M. Freeman, T. Kodama, M. Penman, and M. Krieger. 1990. Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature 343:570-572[CrossRef][Medline]. |
| 54. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 55. | Saravani, G. A., and D. R. Martin. 1990. Opacity factor from group A streptococci is an apoproteinase. FEMS Microbiol. Lett. 56:35-40[CrossRef][Medline]. |
| 56. | Schmidt, K.-H., and T. Wadström. 1990. A secreted receptor related to M1 protein of Streptococcus pyogenes binds to fibrinogen, IgG, and albumin. Zentbl. Bakteriol. 273:216-228. |
| 57. | Sim, R. B., and K. B. M. Reid. 1991. C1: molecular interactions with activating systems. Immunol. Today 12:307-311[CrossRef][Medline]. |
| 58. |
Talay, S. R.,
P. Valentin-Weigand,
P. G. Jerlström,
K. N. Timmis, and G. S. Chhatwal.
1992.
Fibronectin-binding protein of Streptococcus pyogenes: sequence of the binding domain involved in adherence of streptococci to epithelial cells.
Infect. Immun.
60:3837-3844 |
| 59. | Thern, A., L. Stenberg, B. Dahlbäck, and G. Lindahl. 1995. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. J. Immunol. 154:375-386[Abstract]. |
| 60. |
Wexler, D. E.,
D. E. Chenoweth, and P. P. Cleary.
1985.
Mechanism of action of the group A streptococcal C5a inactivator.
Proc. Natl. Acad. Sci. USA
82:8144-8148 |
| 61. | Whatmore, A. M., V. Kapur, D. J. Sullivan, J. M. Musser, and M. A. Kehoe. 1994. Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci. Mol. Microbiol. 14:619-631[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|